The effects of oestrogens and their receptors on cardiometabolic health

Eugenia Morselli, Roberta S. Santos, Alfredo Criollo, Michael D. Nelson, Biff F. Palmer, Deborah J. Clegg

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Cardiovascular disease (CVD) is one of the leading causes of mortality in developed countries. The incidence of CVD is sexually dimorphic, and research has focused on the contribution of sex steroids to the development and progression of the cardiometabolic syndrome, which is defined as a clustering of interrelated risk factors that promote the development of atherosclerosis (which can lead to CVD) and type 2 diabetes mellitus. Data are inconclusive as to how sex steroids and their respective receptors increase or suppress the risk of developing the cardiometabolic syndrome and thus CVD. In this Review, we discuss the potential role, or roles, of sex hormones in cardiometabolic health by first focusing on the influence of oestrogens and their receptors on the risk of developing cardiometabolic syndrome and CVD. We also highlight what is known about testosterone and its potential role in protecting against the development of the cardiometabolic syndrome and CVD. Given the inconclusive nature of the data regarding the direct effects of each sex hormone, we advocate and highlight the importance of studying the relative levels and the ratio of sex hormones to each other, as well as the use of cross sex hormone therapy and its effect on cardiometabolic health.

Original languageEnglish (US)
JournalNature Reviews Endocrinology
DOIs
StateAccepted/In press - Mar 17 2017

Fingerprint

Estrogen Receptors
Cardiovascular Diseases
Gonadal Steroid Hormones
Health
Steroids
Developed Countries
Type 2 Diabetes Mellitus
Cluster Analysis
Testosterone
Atherosclerosis
Mortality
Incidence
Research

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

The effects of oestrogens and their receptors on cardiometabolic health. / Morselli, Eugenia; Santos, Roberta S.; Criollo, Alfredo; Nelson, Michael D.; Palmer, Biff F.; Clegg, Deborah J.

In: Nature Reviews Endocrinology, 17.03.2017.

Research output: Contribution to journalArticle

Morselli, Eugenia ; Santos, Roberta S. ; Criollo, Alfredo ; Nelson, Michael D. ; Palmer, Biff F. ; Clegg, Deborah J. / The effects of oestrogens and their receptors on cardiometabolic health. In: Nature Reviews Endocrinology. 2017.
@article{a6246596c07e4c91af5b79bf1789ed2c,
title = "The effects of oestrogens and their receptors on cardiometabolic health",
abstract = "Cardiovascular disease (CVD) is one of the leading causes of mortality in developed countries. The incidence of CVD is sexually dimorphic, and research has focused on the contribution of sex steroids to the development and progression of the cardiometabolic syndrome, which is defined as a clustering of interrelated risk factors that promote the development of atherosclerosis (which can lead to CVD) and type 2 diabetes mellitus. Data are inconclusive as to how sex steroids and their respective receptors increase or suppress the risk of developing the cardiometabolic syndrome and thus CVD. In this Review, we discuss the potential role, or roles, of sex hormones in cardiometabolic health by first focusing on the influence of oestrogens and their receptors on the risk of developing cardiometabolic syndrome and CVD. We also highlight what is known about testosterone and its potential role in protecting against the development of the cardiometabolic syndrome and CVD. Given the inconclusive nature of the data regarding the direct effects of each sex hormone, we advocate and highlight the importance of studying the relative levels and the ratio of sex hormones to each other, as well as the use of cross sex hormone therapy and its effect on cardiometabolic health.",
author = "Eugenia Morselli and Santos, {Roberta S.} and Alfredo Criollo and Nelson, {Michael D.} and Palmer, {Biff F.} and Clegg, {Deborah J.}",
year = "2017",
month = "3",
day = "17",
doi = "10.1038/nrendo.2017.12",
language = "English (US)",
journal = "Nature Reviews Endocrinology",
issn = "1759-5029",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - The effects of oestrogens and their receptors on cardiometabolic health

AU - Morselli, Eugenia

AU - Santos, Roberta S.

AU - Criollo, Alfredo

AU - Nelson, Michael D.

AU - Palmer, Biff F.

AU - Clegg, Deborah J.

PY - 2017/3/17

Y1 - 2017/3/17

N2 - Cardiovascular disease (CVD) is one of the leading causes of mortality in developed countries. The incidence of CVD is sexually dimorphic, and research has focused on the contribution of sex steroids to the development and progression of the cardiometabolic syndrome, which is defined as a clustering of interrelated risk factors that promote the development of atherosclerosis (which can lead to CVD) and type 2 diabetes mellitus. Data are inconclusive as to how sex steroids and their respective receptors increase or suppress the risk of developing the cardiometabolic syndrome and thus CVD. In this Review, we discuss the potential role, or roles, of sex hormones in cardiometabolic health by first focusing on the influence of oestrogens and their receptors on the risk of developing cardiometabolic syndrome and CVD. We also highlight what is known about testosterone and its potential role in protecting against the development of the cardiometabolic syndrome and CVD. Given the inconclusive nature of the data regarding the direct effects of each sex hormone, we advocate and highlight the importance of studying the relative levels and the ratio of sex hormones to each other, as well as the use of cross sex hormone therapy and its effect on cardiometabolic health.

AB - Cardiovascular disease (CVD) is one of the leading causes of mortality in developed countries. The incidence of CVD is sexually dimorphic, and research has focused on the contribution of sex steroids to the development and progression of the cardiometabolic syndrome, which is defined as a clustering of interrelated risk factors that promote the development of atherosclerosis (which can lead to CVD) and type 2 diabetes mellitus. Data are inconclusive as to how sex steroids and their respective receptors increase or suppress the risk of developing the cardiometabolic syndrome and thus CVD. In this Review, we discuss the potential role, or roles, of sex hormones in cardiometabolic health by first focusing on the influence of oestrogens and their receptors on the risk of developing cardiometabolic syndrome and CVD. We also highlight what is known about testosterone and its potential role in protecting against the development of the cardiometabolic syndrome and CVD. Given the inconclusive nature of the data regarding the direct effects of each sex hormone, we advocate and highlight the importance of studying the relative levels and the ratio of sex hormones to each other, as well as the use of cross sex hormone therapy and its effect on cardiometabolic health.

UR - http://www.scopus.com/inward/record.url?scp=85015692494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015692494&partnerID=8YFLogxK

U2 - 10.1038/nrendo.2017.12

DO - 10.1038/nrendo.2017.12

M3 - Article

C2 - 28304393

AN - SCOPUS:85015692494

JO - Nature Reviews Endocrinology

JF - Nature Reviews Endocrinology

SN - 1759-5029

ER -